RAS Acting Agents Market Growth: Key Drivers and Emerging Oncology Trends
The RAS Acting Agents Market growth is driven by the increasing prevalence of RAS-mutated cancers such as pancreatic, colorectal, and lung cancers. These cancers are often aggressive and difficult to treat using conventional therapies, creating a strong demand for targeted treatment options. RAS acting agents provide a promising solution by directly targeting molecular pathways responsible for...
0 Kommentare 0 Geteilt 3 Ansichten 0 Bewertungen